1. Aortic Aneurysm-associated Disseminated Intravascular Coagulation that Responded Well to a Switch from Warfarin to Rivaroxaban.
- Author
-
Kadohira Y, Yamada S, Matsuura E, Hayashi T, Morishita E, Nakao S, and Asakura H
- Subjects
- Aged, Antineoplastic Agents therapeutic use, Atrial Fibrillation drug therapy, Humans, Lung Neoplasms complications, Lung Neoplasms drug therapy, Male, Warfarin therapeutic use, Anticoagulants therapeutic use, Aortic Aneurysm complications, Disseminated Intravascular Coagulation complications, Disseminated Intravascular Coagulation drug therapy, Rivaroxaban therapeutic use
- Abstract
We describe a case in which uncontrolled chronic disseminated intravascular coagulation (DIC) caused by an aortic aneurysm that was exacerbated by chemotherapy for lung cancer, showed dramatic improvement when warfarin, which was being administered for atrial fibrillation, was replaced by rivaroxaban, a direct oral anticoagulant (DOAC). The present case is interesting because a DOAC was effective in treating DIC due to an aortic aneurysm, whereas warfarin, another oral anticoagulant, was ineffective. In controlling DIC, it is important to inhibit activated coagulation factors such as thrombin and activated factor X, rather than the coagulation factors, which act as substrates.
- Published
- 2017
- Full Text
- View/download PDF